The preferred and most widely analyzed between selective androgen receptor modulators (SARMs), Ostarine —also known as MK-2866, GTX 024, or Enobosarm —arrived on the scene back again from the late nineties as an experimental therapy for osteoporosis and certain conditions that trigger insulin resistance, muscle wasting, and muscle loss.Our prod